Platelet activating factor inhibition reduces lung injury after cardiopulmonary bypass
- 28 February 1995
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 59 (2) , 328-335
- https://doi.org/10.1016/0003-4975(94)00725-m
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Inhibition of neutrophil adhesion during cardiopulmonary bypassThe Annals of Thoracic Surgery, 1994
- Neutrophil adhesion molecule expression during cardiopulmonary bypass with bubble and membrane oxygenatorsThe Annals of Thoracic Surgery, 1993
- Monoclonal antibodies against porcine LFA-1: Species cross-reactivity and functional effects of β-subunit-specific antibodiesMolecular Immunology, 1989
- Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro.Journal of Clinical Investigation, 1989
- Adherence of neutrophils to cultured human microvascular endothelial cells. Stimulation by chemotactic peptides and lipid mediators and dependence upon the Mac-1, LFA-1, p150,95 glycoprotein family.Journal of Clinical Investigation, 1989
- Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 520211Journal of Allergy and Clinical Immunology, 1989
- Neutrophil‐mediated Vascular InjuryActa Medica Scandinavica, 1987
- Platelet-activating factor (PAF-acether), an activator of neutrophil functionsInflammation Research, 1982
- Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites.Journal of Clinical Investigation, 1982
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981